问题 › 我们需要一份给银行的商业计划书 › 专业服务
贷款人不是在看野心。他们是在看最坏情况下,利用率和实现率是否仍能偿还债务。 专业服务机构在此面临特定困境——合伙人薪酬理性地支付人们<em>不</em>去销售公司最高利润率的产品。在解决这个问题之前,可计费利用率将继续因无人能归因的原因而变动,而关于债务服务覆盖的争论仍将是意见问题。
贷款人不是在看野心。他们是在看最坏情况下,利用率和实现率是否仍能偿还债务。 专业服务机构在此面临特定困境——合伙人薪酬理性地支付人们不去销售公司最高利润率的产品。在解决这个问题之前,可计费利用率将继续因无人能归因的原因而变动,而关于债务服务覆盖的争论仍将是意见问题。
为贷款人写的计划书在同一件事上失败:只有一个乐观的单一情景,没有可见的算术。读者想确认如果情况适度变差他们是否能拿回钱,而只有好情景的计划书无法让他们检验合伙人薪酬支付人们不去卖最高利润率产品的结构性困境。
能经得起审查的是一个有明确假设的基础情景,假设涉及可计费利用率、实现率和合伙人杠杆,一个真正糟糕而非温和缩减的坏情景,以及从经营表现到两种情景下债务服务的清晰线条。上行情景最不重要。
第二个失败是不一致——收入线无法与310人的编制计划对上,或者项目毛利率与销售变动不符。贷款人靠阅读这类文件为生,能很快发现这些问题。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 你需要在别人设定的截止日期前拿到文件,而管理合伙人还在模型里调整合伙人杠杆假设。
✓ 预测存在于一张外部没人针对闲置时间或项目利润率变动做过压力测试的表格里。
✓ 没有坏情景,或者坏情景只是基础情景减百分之十,实现率没有变化。
通常会让情况更糟的做法。 把计划书写得有说服力而不是可核查,这是最快失去靠核查为生读者的方式。
It is for you if you run or finance a professional services firm and you need the document by a deadline set by someone else. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家专业服务机构. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Aldergate Partners, a sample company profile used for testing rather than a customer — $88M revenue, 310 people.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Align partner economics so selling an $85K diagnostic becomes as attractive as booking a $340K T&M engagement in the same quarter.
The leak it closes. Eliminates the $1.53M annual leakage where partners book $340K T&M instead of $85K diagnostic + $410K implementation, destroying $325K firm-level margin differential per converted engagement
The assumption it rests on. Partners accept 1.5× diagnostic credit and 10% implementation share rather than exiting — the engine put the probability at 0.75.
| Investment required | $180-240K |
| Expected return | 8.5-11.3× |
| Revenue, year 1 | $2.04M incremental diagnostic revenue + $5.3M implementation follow-on |
| Revenue, year 2 | $3.4M incremental diagnostic revenue + $8.8M implementation follow-on |
| Revenue, year 3 | $4.6M incremental diagnostic revenue + $11.9M implementation follow-on |
| Exit criteria | Terminate if 4 of 5 pilot partners refuse to sign by Month 4 OR if the $9.4M largest account fails to renew in Q3, triggering immediate reversal to legacy compensation model and diagnostic deprioritization |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Business Plan Studio, one of 29 engagements the platform runs. For 专业服务机构 it works through billable utilisation, realisation, revenue per partner and engagement gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
短到能读完,长到能被检验。财务数字和背后的假设决定决策,超出解释所需的故事只会增加风险而非信心。
现金流在非好情景下能否偿还债务,以及数字是否内部一致。几乎其他一切都只是这两个问题的背景。
匹配融资期限,第一年按月。超出贷款期限的细节显示不熟悉而非严谨。
Materially, yes. Partner compensation rationally pays people not to sell the highest-margin product in the firm — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are billable utilisation, realisation, revenue per partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on billable utilisation and realisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית